ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ABX Advanced Biochemical Compounds GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10526
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ABX Advanced Biochemical Compounds GmbH (ABX), a subsidiary of Otsuka Holdings Co Ltd is a provider of biochemical compounds that manufactures, develops, and distributes biochemicals for nuclear medicine. The company provides products such as PET and SPECT precursors and reference standards, reagents kits and cassettes, PET precursors and FDG reagents kits, custom synthesis, particularly kits, peptides, HCI and radiotracers, among others. It offers pharmaceutical kits and cassettes, APIs, ammpse triflate, precursors, glucose triflates, talose triflates, and others. ABX provides products scuh as raclopride, tosyl fallypride, desmethoxyfallypride, fluoroethylspiperone, nitromazenil, flumazenil, harmol, harmine and etomidate, among others. The company also offers synthesis modules such as ora neptis mosaic-RS, siemens Explora one, and ORA mosaic-LC and Scintomics, among others. ABX is headquartered in Radeberg, Germany.

ABX Advanced Biochemical Compounds GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Endocyte Enters into Licensing Agreement with ABX 10
Equity Offering 11
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH – Key Competitors 13
ABX Advanced Biochemical Compounds GmbH – Key Employees 14
ABX Advanced Biochemical Compounds GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ABX Advanced Biochemical Compounds GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Endocyte Enters into Licensing Agreement with ABX 10
Endocyte Raises Funds through Private Placement of Shares and Warrants 11
Endocyte Raises USD4.5 Million in Private Placement of Shares upon Exercise of Warrants 12
ABX Advanced Biochemical Compounds GmbH, Key Competitors 13
ABX Advanced Biochemical Compounds GmbH, Key Employees 14

List of Figures
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ABX Advanced Biochemical Compounds GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[ABX Advanced Biochemical Compounds GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sectra AB (SECT B):医療機器:M&Aディール及び事業提携情報
    Summary Sectra AB (Sectra) develops and sells technologies for medical systems and secure communication systems. Its operations are concentrated on two major sectors: Image IT Solutions and Secure Communications. The company’s subsidiary, Sectra Imaging IT Solutions AB, offers medical information te …
  • Edison International (EIX):電力:M&Aディール及び事業提携情報
    Summary Edison International (Edison) is an energy holding company. The company generates and distributes electric power; and invests in energy services and technologies, including renewable power, through its subsidiaries. It develops solar products and carries out commercial rooftop installation o …
  • The Pep Boys – Manny, Moe & Jack of California:企業の戦略的SWOT分析
    The Pep Boys - Manny, Moe & Jack of California - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Suzuken Co., Ltd.:企業の戦略・SWOT・財務情報
    Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Central Japan Railway Co (9022):企業の財務・戦略的SWOT分析
    Central Japan Railway Co (9022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NWF Group plc (NWF):企業の財務・戦略的SWOT分析
    Summary NWF Group Plc (NWF) is a consumer goods company that offers animal feedstuffs products. The company operates through feeds, food and fuel segments. It offers products such as fuel oil, dairy products, animal feeds and agricultural products. Its offers fuel, food and feed business solutions. …
  • Cesca Therapeutics Inc (KOOL):企業の財務・戦略的SWOT分析
    Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Samsung Electronics Co Ltd.:企業の戦略・SWOT・財務分析
    Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • MAGNA Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MAGNA Pharmaceuticals Inc (Magna) is a pharmaceutical company that offers non-prescription products and prescription products. The company offers dietary supplement, nasal decongestant and drowsiness antihistamine for the treatment of allergy and upper respiratory symptoms. It provides omega …
  • Fossil Group, Inc. (FOSL):企業の財務・戦略的SWOT分析
    Fossil Group, Inc. (FOSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Independent Order of Foresters:企業の戦略的SWOT分析
    The Independent Order of Foresters - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Origin Energy Limited:戦略・SWOT・企業財務分析
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SgurrEnergy Ltd:企業の戦略的SWOT分析
    SgurrEnergy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • Danfoss AS:企業の戦略的SWOT分析
    Danfoss AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • RCL Foods Ltd. (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd. (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務分析
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の財務・戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Biotron Ltd (BIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotron Ltd (Biotron) is a clinical stage biotechnology company which researches, develops and commercializes small molecules for the treatment of infectious diseases. Biotron’s core focus is to design and develop drugs that target viral ion channel proteins (viroporins). The company’s lead …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆